Dr Boreham’s Crucible: Positive Alzheimer’s portents for Actinogen Medical

Actinogen is the only ASX-listed developer of an Alzheimer’s disease treatment and portents are positive, with a phase IIb/III trial ... Read More The post Dr Boreham’s Crucible: Positive Alzheimer’s portents for Actinogen Medical appeared first on Stockhead .

Go to News Site